Healthcare - Biotechnology - NASDAQ - US
$ 2.22
-8.64 %
$ 19.1 M
Market Cap
-0.55
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
41.42%
Net Income
Estimate
29.45%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
NeuroBo Pharmaceuticals, Inc.
NRBO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart NRBO
EBIT FORECAST
EBIT Forecast Chart NRBO
NET INCOME FORECAST
Net Income Chart NRBO